nodes	percent_of_prediction	percent_of_DWPC	metapath
Varenicline—CHRNA3—chronic obstructive pulmonary disease	0.67	1	CbGaD
Varenicline—CHRNA6—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.00612	0.0408	CbGpPWpGaD
Varenicline—CHRNB2—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.00539	0.036	CbGpPWpGaD
Varenicline—CHRNB2—Highly sodium permeable acetylcholine nicotinic receptors—CHRNA3—chronic obstructive pulmonary disease	0.00537	0.0358	CbGpPWpGaD
Varenicline—CHRNA6—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.00521	0.0348	CbGpPWpGaD
Varenicline—CHRNA6—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.00499	0.0333	CbGpPWpGaD
Varenicline—CHRNA6—Presynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.00486	0.0324	CbGpPWpGaD
Varenicline—CHRNB2—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.00459	0.0306	CbGpPWpGaD
Varenicline—CHRNB2—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.00439	0.0293	CbGpPWpGaD
Varenicline—CHRNA6—Acetylcholine Binding And Downstream Events—CHRNA5—chronic obstructive pulmonary disease	0.0043	0.0287	CbGpPWpGaD
Varenicline—CHRNB2—Presynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.00428	0.0286	CbGpPWpGaD
Varenicline—CHRNA6—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.00425	0.0284	CbGpPWpGaD
Varenicline—CHRNA6—Presynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.00396	0.0264	CbGpPWpGaD
Varenicline—CHRNA3—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.00388	0.0259	CbGpPWpGaD
Varenicline—CHRNB2—Acetylcholine Binding And Downstream Events—CHRNA5—chronic obstructive pulmonary disease	0.00378	0.0252	CbGpPWpGaD
Varenicline—CHRNB2—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.00374	0.025	CbGpPWpGaD
Varenicline—CHRNA6—Acetylcholine Binding And Downstream Events—CHRNA3—chronic obstructive pulmonary disease	0.0035	0.0234	CbGpPWpGaD
Varenicline—CHRNB2—Presynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.00349	0.0233	CbGpPWpGaD
Varenicline—CHRNA3—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.0033	0.0221	CbGpPWpGaD
Varenicline—CHRNA7—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.00313	0.0209	CbGpPWpGaD
Varenicline—CHRNA6—Nicotine Activity on Dopaminergic Neurons—CHRNA5—chronic obstructive pulmonary disease	0.00311	0.0207	CbGpPWpGaD
Varenicline—CHRNB2—Acetylcholine Binding And Downstream Events—CHRNA3—chronic obstructive pulmonary disease	0.00308	0.0206	CbGpPWpGaD
Varenicline—CHRNA3—Presynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.00308	0.0206	CbGpPWpGaD
Varenicline—CHRNA4—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.003	0.02	CbGpPWpGaD
Varenicline—CHRNA4—Highly sodium permeable acetylcholine nicotinic receptors—CHRNA3—chronic obstructive pulmonary disease	0.00299	0.02	CbGpPWpGaD
Varenicline—CHRNB2—Nicotine Activity on Dopaminergic Neurons—CHRNA5—chronic obstructive pulmonary disease	0.00273	0.0183	CbGpPWpGaD
Varenicline—CHRNA3—Acetylcholine Binding And Downstream Events—CHRNA5—chronic obstructive pulmonary disease	0.00272	0.0182	CbGpPWpGaD
Varenicline—CHRNA7—Acetylcholine Binding And Downstream Events—CHRNA5—chronic obstructive pulmonary disease	0.00258	0.0173	CbGpPWpGaD
Varenicline—CHRNA7—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.00256	0.0171	CbGpPWpGaD
Varenicline—CHRNA4—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.00256	0.0171	CbGpPWpGaD
Varenicline—CHRNA6—Nicotine Activity on Dopaminergic Neurons—CHRNA3—chronic obstructive pulmonary disease	0.00253	0.0169	CbGpPWpGaD
Varenicline—CHRNA4—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.00245	0.0163	CbGpPWpGaD
Varenicline—CHRNA4—Presynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.00238	0.0159	CbGpPWpGaD
Varenicline—CHRNB2—Nicotine Activity on Dopaminergic Neurons—CHRNA3—chronic obstructive pulmonary disease	0.00223	0.0149	CbGpPWpGaD
Varenicline—CHRNA4—Acetylcholine Binding And Downstream Events—CHRNA5—chronic obstructive pulmonary disease	0.00211	0.0141	CbGpPWpGaD
Varenicline—CHRNA7—Acetylcholine Binding And Downstream Events—CHRNA3—chronic obstructive pulmonary disease	0.00211	0.0141	CbGpPWpGaD
Varenicline—CHRNA4—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.00208	0.0139	CbGpPWpGaD
Varenicline—CHRNA3—Nicotine Activity on Dopaminergic Neurons—CHRNA5—chronic obstructive pulmonary disease	0.00197	0.0131	CbGpPWpGaD
Varenicline—CHRNA4—Presynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.00194	0.013	CbGpPWpGaD
Varenicline—CHRNA4—Acetylcholine Binding And Downstream Events—CHRNA3—chronic obstructive pulmonary disease	0.00172	0.0115	CbGpPWpGaD
Varenicline—CHRNA3—respiratory system—chronic obstructive pulmonary disease	0.00158	0.134	CbGeAlD
Varenicline—CHRNA4—Nicotine Activity on Dopaminergic Neurons—CHRNA5—chronic obstructive pulmonary disease	0.00152	0.0102	CbGpPWpGaD
Varenicline—CHRNB2—bronchus—chronic obstructive pulmonary disease	0.00134	0.114	CbGeAlD
Varenicline—CHRNB2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00131	0.112	CbGeAlD
Varenicline—CHRFAM7A—respiratory system—chronic obstructive pulmonary disease	0.00128	0.109	CbGeAlD
Varenicline—CHRNA4—Nicotine Activity on Dopaminergic Neurons—CHRNA3—chronic obstructive pulmonary disease	0.00124	0.00829	CbGpPWpGaD
Varenicline—CHRNB2—trachea—chronic obstructive pulmonary disease	0.0012	0.102	CbGeAlD
Varenicline—CHRNA4—respiratory system—chronic obstructive pulmonary disease	0.00102	0.0866	CbGeAlD
Varenicline—CHRFAM7A—trachea—chronic obstructive pulmonary disease	0.000943	0.0803	CbGeAlD
Varenicline—CHRNB2—lung—chronic obstructive pulmonary disease	0.000864	0.0736	CbGeAlD
Varenicline—CHRNA3—lung—chronic obstructive pulmonary disease	0.000838	0.0713	CbGeAlD
Varenicline—CHRNA4—bronchus—chronic obstructive pulmonary disease	0.000837	0.0713	CbGeAlD
Varenicline—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000681	0.00455	CbGpPWpGaD
Varenicline—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000599	0.004	CbGpPWpGaD
Varenicline—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000555	0.00371	CbGpPWpGaD
Varenicline—CHRNA4—lung—chronic obstructive pulmonary disease	0.00054	0.046	CbGeAlD
Varenicline—CHRNA6—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000512	0.00342	CbGpPWpGaD
Varenicline—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000489	0.00326	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000451	0.00301	CbGpPWpGaD
Varenicline—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000432	0.00288	CbGpPWpGaD
Varenicline—CHRNA6—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000417	0.00279	CbGpPWpGaD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00041	0.00273	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000392	0.00262	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000369	0.00246	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000367	0.00245	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000345	0.00231	CbGpPWpGaD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000334	0.00223	CbGpPWpGaD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000334	0.00223	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000333	0.00222	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000324	0.00217	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00032	0.00213	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000308	0.00206	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000281	0.00188	CbGpPWpGaD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000272	0.00182	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.000272	0.00182	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000252	0.00168	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000251	0.00168	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000251	0.00168	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.00025	0.00167	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000249	0.00166	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000249	0.00166	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000236	0.00158	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000231	0.00154	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000228	0.00152	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000206	0.00137	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000205	0.00137	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000204	0.00136	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000192	0.00128	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000192	0.00128	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000186	0.00124	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000158	0.00105	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000157	0.00105	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000155	0.00104	CbGpPWpGaD
Varenicline—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.000885	CcSEcCtD
Varenicline—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.000885	CcSEcCtD
Varenicline—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.000885	CcSEcCtD
Varenicline—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000149	0.000884	CcSEcCtD
Varenicline—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.000882	CcSEcCtD
Varenicline—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000149	0.000881	CcSEcCtD
Varenicline—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.000881	CcSEcCtD
Varenicline—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000148	0.00088	CcSEcCtD
Varenicline—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000148	0.00088	CcSEcCtD
Varenicline—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000148	0.000876	CcSEcCtD
Varenicline—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.000876	CcSEcCtD
Varenicline—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.000874	CcSEcCtD
Varenicline—Infection—Montelukast—chronic obstructive pulmonary disease	0.000147	0.000874	CcSEcCtD
Varenicline—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.000872	CcSEcCtD
Varenicline—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000147	0.000872	CcSEcCtD
Varenicline—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000147	0.000869	CcSEcCtD
Varenicline—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.000865	CcSEcCtD
Varenicline—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000146	0.000863	CcSEcCtD
Varenicline—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000145	0.000861	CcSEcCtD
Varenicline—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000145	0.000861	CcSEcCtD
Varenicline—CHRNB2—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000145	0.000965	CbGpPWpGaD
Varenicline—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000144	0.000854	CcSEcCtD
Varenicline—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000851	CcSEcCtD
Varenicline—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.000848	CcSEcCtD
Varenicline—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.000842	CcSEcCtD
Varenicline—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000142	0.000839	CcSEcCtD
Varenicline—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.000839	CcSEcCtD
Varenicline—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000141	0.000835	CcSEcCtD
Varenicline—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.000834	CcSEcCtD
Varenicline—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.000832	CcSEcCtD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.00014	0.000932	CbGpPWpGaD
Varenicline—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.000828	CcSEcCtD
Varenicline—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000827	CcSEcCtD
Varenicline—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.000824	CcSEcCtD
Varenicline—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000138	0.00082	CcSEcCtD
Varenicline—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.00082	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000138	0.000818	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000138	0.000818	CcSEcCtD
Varenicline—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000137	0.000812	CcSEcCtD
Varenicline—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000137	0.000812	CcSEcCtD
Varenicline—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000136	0.000808	CcSEcCtD
Varenicline—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000136	0.000807	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000135	0.000801	CcSEcCtD
Varenicline—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.000801	CcSEcCtD
Varenicline—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000135	0.000801	CcSEcCtD
Varenicline—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000135	0.000798	CcSEcCtD
Varenicline—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.000798	CcSEcCtD
Varenicline—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000134	0.000796	CcSEcCtD
Varenicline—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.000792	CcSEcCtD
Varenicline—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000133	0.000791	CcSEcCtD
Varenicline—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000133	0.000791	CcSEcCtD
Varenicline—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000133	0.000787	CcSEcCtD
Varenicline—Injury—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000782	CcSEcCtD
Varenicline—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000132	0.000782	CcSEcCtD
Varenicline—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000132	0.00078	CcSEcCtD
Varenicline—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000131	0.000778	CcSEcCtD
Varenicline—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000131	0.000775	CcSEcCtD
Varenicline—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000131	0.000775	CcSEcCtD
Varenicline—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000131	0.000774	CcSEcCtD
Varenicline—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000131	0.000774	CcSEcCtD
Varenicline—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000131	0.000774	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.000773	CcSEcCtD
Varenicline—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00013	0.000768	CcSEcCtD
Varenicline—Pain—Formoterol—chronic obstructive pulmonary disease	0.00013	0.000768	CcSEcCtD
Varenicline—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00013	0.000768	CcSEcCtD
Varenicline—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00013	0.000768	CcSEcCtD
Varenicline—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.000767	CcSEcCtD
Varenicline—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000765	CcSEcCtD
Varenicline—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000765	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000129	0.000858	CbGpPWpGaD
Varenicline—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000128	0.000759	CcSEcCtD
Varenicline—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000128	0.000758	CcSEcCtD
Varenicline—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.000756	CcSEcCtD
Varenicline—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.000754	CcSEcCtD
Varenicline—Pain—Montelukast—chronic obstructive pulmonary disease	0.000127	0.000752	CcSEcCtD
Varenicline—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.000752	CcSEcCtD
Varenicline—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000127	0.00075	CcSEcCtD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000126	0.000843	CbGpPWpGaD
Varenicline—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.000748	CcSEcCtD
Varenicline—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.000746	CcSEcCtD
Varenicline—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000125	0.000744	CcSEcCtD
Varenicline—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000125	0.000743	CcSEcCtD
Varenicline—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000125	0.000741	CcSEcCtD
Varenicline—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000125	0.00074	CcSEcCtD
Varenicline—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000125	0.00074	CcSEcCtD
Varenicline—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000125	0.000739	CcSEcCtD
Varenicline—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000124	0.000737	CcSEcCtD
Varenicline—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000124	0.000736	CcSEcCtD
Varenicline—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000124	0.000734	CcSEcCtD
Varenicline—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.000734	CcSEcCtD
Varenicline—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000734	CcSEcCtD
Varenicline—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.000732	CcSEcCtD
Varenicline—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.000731	CcSEcCtD
Varenicline—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.000725	CcSEcCtD
Varenicline—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.000725	CcSEcCtD
Varenicline—CHRNB2—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000122	0.000812	CbGpPWpGaD
Varenicline—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000121	0.000719	CcSEcCtD
Varenicline—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000719	CcSEcCtD
Varenicline—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000719	CcSEcCtD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000121	0.000808	CbGpPWpGaD
Varenicline—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00012	0.000713	CcSEcCtD
Varenicline—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00012	0.000713	CcSEcCtD
Varenicline—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00012	0.00071	CcSEcCtD
Varenicline—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00012	0.00071	CcSEcCtD
Varenicline—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00012	0.00071	CcSEcCtD
Varenicline—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00012	0.00071	CcSEcCtD
Varenicline—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000708	CcSEcCtD
Varenicline—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000119	0.000708	CcSEcCtD
Varenicline—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000702	CcSEcCtD
Varenicline—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000118	0.000702	CcSEcCtD
Varenicline—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000118	0.000701	CcSEcCtD
Varenicline—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000118	0.000701	CcSEcCtD
Varenicline—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000118	0.000699	CcSEcCtD
Varenicline—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.000699	CcSEcCtD
Varenicline—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000118	0.000697	CcSEcCtD
Varenicline—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.000697	CcSEcCtD
Varenicline—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000117	0.000695	CcSEcCtD
Varenicline—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000117	0.000695	CcSEcCtD
Varenicline—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.000693	CcSEcCtD
Varenicline—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000686	CcSEcCtD
Varenicline—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000681	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000114	0.00076	CbGpPWpGaD
Varenicline—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.000674	CcSEcCtD
Varenicline—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.00067	CcSEcCtD
Varenicline—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.00067	CcSEcCtD
Varenicline—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000112	0.000662	CcSEcCtD
Varenicline—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000112	0.000662	CcSEcCtD
Varenicline—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000111	0.000661	CcSEcCtD
Varenicline—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.00066	CcSEcCtD
Varenicline—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000659	CcSEcCtD
Varenicline—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000654	CcSEcCtD
Varenicline—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000109	0.000648	CcSEcCtD
Varenicline—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000109	0.000644	CcSEcCtD
Varenicline—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000109	0.000644	CcSEcCtD
Varenicline—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.000635	CcSEcCtD
Varenicline—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000107	0.000635	CcSEcCtD
Varenicline—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000106	0.000631	CcSEcCtD
Varenicline—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000626	CcSEcCtD
Varenicline—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.000625	CcSEcCtD
Varenicline—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000105	0.000622	CcSEcCtD
Varenicline—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000104	0.000614	CcSEcCtD
Varenicline—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000104	0.000614	CcSEcCtD
Varenicline—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.000612	CcSEcCtD
Varenicline—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.000608	CcSEcCtD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000103	0.000684	CbGpPWpGaD
Varenicline—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000102	0.000602	CcSEcCtD
Varenicline—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.0006	CcSEcCtD
Varenicline—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.000596	CcSEcCtD
Varenicline—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.0001	0.000594	CcSEcCtD
Varenicline—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.0001	0.000594	CcSEcCtD
Varenicline—Dizziness—Montelukast—chronic obstructive pulmonary disease	9.81e-05	0.000582	CcSEcCtD
Varenicline—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	9.79e-05	0.00058	CcSEcCtD
Varenicline—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	9.65e-05	0.000572	CcSEcCtD
Varenicline—Vomiting—Formoterol—chronic obstructive pulmonary disease	9.63e-05	0.000571	CcSEcCtD
Varenicline—Vomiting—Arformoterol—chronic obstructive pulmonary disease	9.63e-05	0.000571	CcSEcCtD
Varenicline—Rash—Arformoterol—chronic obstructive pulmonary disease	9.55e-05	0.000566	CcSEcCtD
Varenicline—Rash—Formoterol—chronic obstructive pulmonary disease	9.55e-05	0.000566	CcSEcCtD
Varenicline—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	9.54e-05	0.000566	CcSEcCtD
Varenicline—Dermatitis—Formoterol—chronic obstructive pulmonary disease	9.54e-05	0.000566	CcSEcCtD
Varenicline—Weight increased—Prednisone—chronic obstructive pulmonary disease	9.54e-05	0.000566	CcSEcCtD
Varenicline—Headache—Formoterol—chronic obstructive pulmonary disease	9.49e-05	0.000563	CcSEcCtD
Varenicline—Headache—Arformoterol—chronic obstructive pulmonary disease	9.49e-05	0.000563	CcSEcCtD
Varenicline—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	9.47e-05	0.000562	CcSEcCtD
Varenicline—Dizziness—Salbutamol—chronic obstructive pulmonary disease	9.46e-05	0.000561	CcSEcCtD
Varenicline—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	9.46e-05	0.000561	CcSEcCtD
Varenicline—Vomiting—Montelukast—chronic obstructive pulmonary disease	9.43e-05	0.000559	CcSEcCtD
Varenicline—Rash—Montelukast—chronic obstructive pulmonary disease	9.35e-05	0.000555	CcSEcCtD
Varenicline—Dermatitis—Montelukast—chronic obstructive pulmonary disease	9.35e-05	0.000554	CcSEcCtD
Varenicline—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	9.33e-05	0.000553	CcSEcCtD
Varenicline—Depression—Prednisone—chronic obstructive pulmonary disease	9.32e-05	0.000553	CcSEcCtD
Varenicline—Headache—Montelukast—chronic obstructive pulmonary disease	9.29e-05	0.000551	CcSEcCtD
Varenicline—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	9.21e-05	0.000546	CcSEcCtD
Varenicline—Angioedema—Prednisolone—chronic obstructive pulmonary disease	9.18e-05	0.000545	CcSEcCtD
Varenicline—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	9.16e-05	0.000543	CcSEcCtD
Varenicline—Vomiting—Salbutamol—chronic obstructive pulmonary disease	9.09e-05	0.000539	CcSEcCtD
Varenicline—Malaise—Prednisolone—chronic obstructive pulmonary disease	9.06e-05	0.000537	CcSEcCtD
Varenicline—Vertigo—Prednisolone—chronic obstructive pulmonary disease	9.03e-05	0.000535	CcSEcCtD
Varenicline—Rash—Salbutamol—chronic obstructive pulmonary disease	9.02e-05	0.000535	CcSEcCtD
Varenicline—Syncope—Prednisolone—chronic obstructive pulmonary disease	9.01e-05	0.000534	CcSEcCtD
Varenicline—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	9.01e-05	0.000534	CcSEcCtD
Varenicline—Nausea—Arformoterol—chronic obstructive pulmonary disease	9e-05	0.000533	CcSEcCtD
Varenicline—Nausea—Formoterol—chronic obstructive pulmonary disease	9e-05	0.000533	CcSEcCtD
Varenicline—Headache—Salbutamol—chronic obstructive pulmonary disease	8.96e-05	0.000531	CcSEcCtD
Varenicline—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	8.83e-05	0.000524	CcSEcCtD
Varenicline—Nausea—Montelukast—chronic obstructive pulmonary disease	8.81e-05	0.000522	CcSEcCtD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	8.79e-05	0.000587	CbGpPWpGaD
Varenicline—Convulsion—Prednisolone—chronic obstructive pulmonary disease	8.71e-05	0.000516	CcSEcCtD
Varenicline—Hypertension—Prednisolone—chronic obstructive pulmonary disease	8.68e-05	0.000515	CcSEcCtD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	8.62e-05	0.000576	CbGpPWpGaD
Varenicline—Bradycardia—Prednisone—chronic obstructive pulmonary disease	8.54e-05	0.000506	CcSEcCtD
Varenicline—Nausea—Salbutamol—chronic obstructive pulmonary disease	8.5e-05	0.000504	CcSEcCtD
Varenicline—Discomfort—Prednisolone—chronic obstructive pulmonary disease	8.46e-05	0.000501	CcSEcCtD
Varenicline—Hallucination—Prednisone—chronic obstructive pulmonary disease	8.35e-05	0.000495	CcSEcCtD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	8.27e-05	0.000552	CbGpPWpGaD
Varenicline—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	8.25e-05	0.000489	CcSEcCtD
Varenicline—Oedema—Prednisolone—chronic obstructive pulmonary disease	8.2e-05	0.000486	CcSEcCtD
Varenicline—Shock—Prednisolone—chronic obstructive pulmonary disease	8.07e-05	0.000478	CcSEcCtD
Varenicline—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	8.01e-05	0.000475	CcSEcCtD
Varenicline—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	7.93e-05	0.00047	CcSEcCtD
Varenicline—Eye disorder—Prednisone—chronic obstructive pulmonary disease	7.84e-05	0.000465	CcSEcCtD
Varenicline—Angiopathy—Prednisone—chronic obstructive pulmonary disease	7.61e-05	0.000451	CcSEcCtD
Varenicline—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	7.58e-05	0.000449	CcSEcCtD
Varenicline—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	7.5e-05	0.000444	CcSEcCtD
Varenicline—Insomnia—Prednisolone—chronic obstructive pulmonary disease	7.42e-05	0.00044	CcSEcCtD
Varenicline—Mental disorder—Prednisone—chronic obstructive pulmonary disease	7.35e-05	0.000436	CcSEcCtD
Varenicline—Malnutrition—Prednisone—chronic obstructive pulmonary disease	7.3e-05	0.000433	CcSEcCtD
Varenicline—Erythema—Prednisone—chronic obstructive pulmonary disease	7.3e-05	0.000433	CcSEcCtD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	7.09e-05	0.000473	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	7.03e-05	0.000469	CbGpPWpGaD
Varenicline—Pain—Prednisolone—chronic obstructive pulmonary disease	7.02e-05	0.000416	CcSEcCtD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	7e-05	0.000468	CbGpPWpGaD
Varenicline—Vision blurred—Prednisone—chronic obstructive pulmonary disease	6.88e-05	0.000408	CcSEcCtD
Varenicline—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	6.78e-05	0.000402	CcSEcCtD
Varenicline—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	6.76e-05	0.000401	CcSEcCtD
Varenicline—Anaemia—Prednisone—chronic obstructive pulmonary disease	6.75e-05	0.0004	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	6.74e-05	0.00045	CbGpPWpGaD
Varenicline—Agitation—Prednisone—chronic obstructive pulmonary disease	6.71e-05	0.000398	CcSEcCtD
Varenicline—Angioedema—Prednisone—chronic obstructive pulmonary disease	6.67e-05	0.000396	CcSEcCtD
Varenicline—Malaise—Prednisone—chronic obstructive pulmonary disease	6.59e-05	0.000391	CcSEcCtD
Varenicline—Vertigo—Prednisone—chronic obstructive pulmonary disease	6.56e-05	0.000389	CcSEcCtD
Varenicline—Syncope—Prednisone—chronic obstructive pulmonary disease	6.55e-05	0.000388	CcSEcCtD
Varenicline—Urticaria—Prednisolone—chronic obstructive pulmonary disease	6.52e-05	0.000386	CcSEcCtD
Varenicline—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	6.42e-05	0.000381	CcSEcCtD
Varenicline—Convulsion—Prednisone—chronic obstructive pulmonary disease	6.33e-05	0.000375	CcSEcCtD
Varenicline—CHRNB2—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	6.32e-05	0.000422	CbGpPWpGaD
Varenicline—Hypertension—Prednisone—chronic obstructive pulmonary disease	6.31e-05	0.000374	CcSEcCtD
Varenicline—Arthralgia—Prednisone—chronic obstructive pulmonary disease	6.22e-05	0.000369	CcSEcCtD
Varenicline—Myalgia—Prednisone—chronic obstructive pulmonary disease	6.22e-05	0.000369	CcSEcCtD
Varenicline—Anxiety—Prednisone—chronic obstructive pulmonary disease	6.2e-05	0.000367	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	6.18e-05	0.000366	CcSEcCtD
Varenicline—Discomfort—Prednisone—chronic obstructive pulmonary disease	6.14e-05	0.000364	CcSEcCtD
Varenicline—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	6.04e-05	0.000358	CcSEcCtD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	6e-05	0.000401	CbGpPWpGaD
Varenicline—Oedema—Prednisone—chronic obstructive pulmonary disease	5.96e-05	0.000353	CcSEcCtD
Varenicline—Infection—Prednisone—chronic obstructive pulmonary disease	5.92e-05	0.000351	CcSEcCtD
Varenicline—Shock—Prednisone—chronic obstructive pulmonary disease	5.86e-05	0.000348	CcSEcCtD
Varenicline—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	5.85e-05	0.000347	CcSEcCtD
Varenicline—Tachycardia—Prednisone—chronic obstructive pulmonary disease	5.82e-05	0.000345	CcSEcCtD
Varenicline—Skin disorder—Prednisone—chronic obstructive pulmonary disease	5.79e-05	0.000343	CcSEcCtD
Varenicline—CHRNB2—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	5.79e-05	0.000386	CbGpPWpGaD
Varenicline—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	5.76e-05	0.000342	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	5.71e-05	0.000381	CbGpPWpGaD
Varenicline—Anorexia—Prednisone—chronic obstructive pulmonary disease	5.68e-05	0.000337	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	5.43e-05	0.000322	CcSEcCtD
Varenicline—Dizziness—Prednisolone—chronic obstructive pulmonary disease	5.42e-05	0.000322	CcSEcCtD
Varenicline—Insomnia—Prednisone—chronic obstructive pulmonary disease	5.39e-05	0.00032	CcSEcCtD
Varenicline—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	5.25e-05	0.000311	CcSEcCtD
Varenicline—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	5.18e-05	0.000307	CcSEcCtD
Varenicline—Rash—Prednisolone—chronic obstructive pulmonary disease	5.17e-05	0.000307	CcSEcCtD
Varenicline—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	5.17e-05	0.000306	CcSEcCtD
Varenicline—Fatigue—Prednisone—chronic obstructive pulmonary disease	5.14e-05	0.000305	CcSEcCtD
Varenicline—Headache—Prednisolone—chronic obstructive pulmonary disease	5.14e-05	0.000305	CcSEcCtD
Varenicline—Constipation—Prednisone—chronic obstructive pulmonary disease	5.1e-05	0.000302	CcSEcCtD
Varenicline—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	4.91e-05	0.000291	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	4.89e-05	0.000327	CbGpPWpGaD
Varenicline—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	4.87e-05	0.000289	CcSEcCtD
Varenicline—Nausea—Prednisolone—chronic obstructive pulmonary disease	4.87e-05	0.000289	CcSEcCtD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	4.84e-05	0.000323	CbGpPWpGaD
Varenicline—Urticaria—Prednisone—chronic obstructive pulmonary disease	4.74e-05	0.000281	CcSEcCtD
Varenicline—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	4.71e-05	0.000279	CcSEcCtD
Varenicline—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	4.71e-05	0.000279	CcSEcCtD
Varenicline—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	4.39e-05	0.00026	CcSEcCtD
Varenicline—Asthenia—Prednisone—chronic obstructive pulmonary disease	4.28e-05	0.000254	CcSEcCtD
Varenicline—Pruritus—Prednisone—chronic obstructive pulmonary disease	4.22e-05	0.00025	CcSEcCtD
Varenicline—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.08e-05	0.000242	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	3.95e-05	0.000264	CbGpPWpGaD
Varenicline—Dizziness—Prednisone—chronic obstructive pulmonary disease	3.94e-05	0.000234	CcSEcCtD
Varenicline—Vomiting—Prednisone—chronic obstructive pulmonary disease	3.79e-05	0.000225	CcSEcCtD
Varenicline—Rash—Prednisone—chronic obstructive pulmonary disease	3.76e-05	0.000223	CcSEcCtD
Varenicline—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.76e-05	0.000223	CcSEcCtD
Varenicline—Headache—Prednisone—chronic obstructive pulmonary disease	3.73e-05	0.000221	CcSEcCtD
Varenicline—Nausea—Prednisone—chronic obstructive pulmonary disease	3.54e-05	0.00021	CcSEcCtD
